tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BNOX Stock Latest News

Bionomics initiates patient screening for the Phase 3 AFFIRM-1 trial
The FlyBionomics initiates patient screening for the Phase 3 AFFIRM-1 trial
6d ago
BNOX
Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder
PremiumPress Releases
Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder
6d ago
BNOX
Bionomics files to sell 3.64B ordinary shares for holders
PremiumThe Fly
Bionomics files to sell 3.64B ordinary shares for holders
1M ago
BNOX
Bionomics Secures Growth Through Strategic Sale
PremiumCompany Announcements
Bionomics Secures Growth Through Strategic Sale
2M ago
6K
BNOX
Bionomics Limited Announces Private Placement of up to $70.0 Million
PremiumPress Releases
Bionomics Limited Announces Private Placement of up to $70.0 Million
2M ago
BNOX
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
PremiumPress ReleasesBionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
2M ago
BNOX
Bionomics’ BNC210 shows significant improvement in PTSD
PremiumThe Fly
Bionomics’ BNC210 shows significant improvement in PTSD
4M ago
BNOX
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
PremiumPress Releases
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
4M ago
BNOX
Bionomics to Present at the 2024 BIO CEO & Investor Conference
PremiumPress Releases
Bionomics to Present at the 2024 BIO CEO & Investor Conference
5M ago
BNOX
Bionomics provides update on BNC210 development
PremiumThe Fly
Bionomics provides update on BNC210 development
6M ago
BNOX
Bionomics Provides a Review of 2023 and of 2024 Plans
PremiumPress Releases
Bionomics Provides a Review of 2023 and of 2024 Plans
6M ago
BNOX
Bionomics to Present at Biotech Showcase™ 2024
PremiumPress Releases
Bionomics to Present at Biotech Showcase™ 2024
7M ago
BNOX
Bionomics presents detailed data on validity, reliability of SUDS
PremiumThe FlyBionomics presents detailed data on validity, reliability of SUDS
8M ago
BNOX
Bionomics announces end-of-Phase 2 meeting with FDA, solidifies plan for BNC210
PremiumThe Fly
Bionomics announces end-of-Phase 2 meeting with FDA, solidifies plan for BNC210
9M ago
BNOX
Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder
PremiumPress Releases
Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder
9M ago
BNOX
Bionomics price target raised to $10 from $7 at Maxim
PremiumThe Fly
Bionomics price target raised to $10 from $7 at Maxim
10M ago
BNOX
H.C. Wainwright upgrades Bionomics to Buy after PTSD study win
PremiumThe Fly
H.C. Wainwright upgrades Bionomics to Buy after PTSD study win
10M ago
BNOX
Bionomics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
Bionomics upgraded to Buy from Neutral at H.C. Wainwright
10M ago
BNOX
William Blair reiterates Outperform on Bionomics after ‘significant win’
PremiumThe Fly
William Blair reiterates Outperform on Bionomics after ‘significant win’
10M ago
BNOX
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
PremiumPress ReleasesBionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
10M ago
BNOX
Bionomics reports ‘positive’ results from Phase 2b ATTUNE trial of BNC210
PremiumThe Fly
Bionomics reports ‘positive’ results from Phase 2b ATTUNE trial of BNC210
10M ago
BNOX
Bionomics provides update on Merck collaboration
PremiumThe Fly
Bionomics provides update on Merck collaboration
10M ago
MRK
BNOX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >